about
Cytochrome P450 family 1 subfamily A member 1Coagulation factor IIInterleukin 6GLI-Kruppel family member GLI1Transforming growth factor, beta 1BCL2-associated X proteinAurora kinase AMidkineTransforming growth factor, beta 2Solute carrier family 1 (glial high affinity glutamate transporter), member 3Caspase 3Paired box 6Glial cell line derived neurotrophic factorCytochrome P450, family 1, subfamily a, polypeptide 1Transforming growth factor beta 1Serpin family E member 2Arginase 1Mitogen-activated protein kinase kinase 4Abhydrolase domain containing 2, acylglycerol lipaseAminoacyl tRNA synthetase complex interacting multifunctional protein 1Integrin subunit beta 4RHO family interacting cell polarization regulator 1Coagulation factor II thrombin receptorProhibitin 2Inhibin subunit beta AHomeobox B13Inhibin subunit beta BCoagulation factor II thrombin receptor like 2Odontogenic, ameloblast associatedNicotinamide nucleotide adenylyltransferase 1ZFP36 ring finger proteinSynaptotagmin 11C-C motif chemokine receptor 1Hematopoietically expressed homeoboxSolute carrier family 1 member 2Neuropilin 1SRY-box transcription factor 2Ribosomal protein S6 kinase B1Bromodomain PHD finger transcription factorVasohibin 1
P682
RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptidesFractalkine-mediated endothelial cell injury by NK cellsTumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblastsThe structure of human prokallikrein 6 reveals a novel activation mechanism for the kallikrein familyHuman GAP-43: its deduced amino acid sequence and chromosomal localization in mouse and humanStem cell markers in the human posterior limbus and corneal endothelium of unwounded and wounded corneasTGF-beta1 and TGF-beta2 expression after traumatic human spinal cord injuryThe function of KGF in morphogenesis of epithelium and reepithelialization of woundsMolecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tailsFurther characterization of the NH2-terminal fibrin-binding site on fibronectinProtease-activated receptor 3 is a second thrombin receptor in humansPlatelet and von Willebrand factor interactions at the vessel wallTwo PDGF-B chain residues, arginine 27 and isoleucine 30, mediate receptor binding and activationCloning and characterization of human protease-activated receptor 4Cardiac myocytes rendered ischemia resistant by expressing the human adenosine A1 or A3 receptor
P921
Q14852020-363611B7-0862-49AA-9464-E16D4BEB87DAQ1509074-5F76ECB0-9F00-4986-B4E5-C898E041673EQ21132158-19FD369F-82E3-4FEE-9DE1-DB6FEBC3FB43Q21422569-43079AA3-D5AC-4EC9-8729-D3136737F712Q22272065-FF23AABD-877B-4860-859F-012230DC07ABQ22272544-29D1C471-3C4E-4659-8548-7FDBF24799FBQ22272675-FF3180D7-4C48-4F5C-A5C1-C6089A5C86CD
P279
Q1407929-A70586DD-D7C4-4E1A-BE22-5E292F2E14AFQ14821020-44B3606D-4575-4294-BD34-0E5E443B43DCQ14865240-ACFDA00F-FB10-4C58-80A6-D6BBF652E69DQ14886456-226C7E83-C3F0-4830-8E62-4E175DEC1D60Q14904616-DCE7B527-7767-4543-A1F4-DFA88C7F26F7Q14905404-C09327ED-4646-4852-9B1A-2B4A191ECCB7Q14906052-E7D61357-4DE1-45B5-8CD9-52FA12BAC2B9Q14907404-FED6ED62-F3EC-4678-BA27-61D902D66ED5Q14908058-9F9C9117-A2B5-47B1-8FDA-2A83179CD2EAQ14913173-0B0CCA03-17FE-4E94-AE71-72CA17CEF332Q14914375-E5B5D8FE-21FB-480A-87CA-1C507AAAC42EQ14916221-35C2BA07-CF60-4C6A-8BC7-DCA69414D7D6Q14916288-1D3C17C1-1668-47F6-9760-B06B59D1A3F6Q14916463-C9C3923A-8FA6-4416-B5F2-69232ABF81E4Q2062543-D81B554B-AD11-4A0C-A87B-C8BA6B8B7787Q21101258-646F75F2-0FD1-4628-A919-9E2C3E155673Q21101888-E1182136-A528-41D1-A2D4-A4559627CC4CQ21104645-C20F3FA6-6E15-419C-87BE-EDEADC7FBAA9Q21104735-531DEC3C-A4B7-48F9-8473-AF79FFCE7119Q21105081-7E279608-6808-4222-BFEF-EEDC60287664Q21105257-2A9B601F-20F8-4B15-866B-7B5BEAFD2980Q21105965-5E499254-6797-4A00-A0DC-74EE0CAA1C18Q21106737-DB58C5F6-3A32-4B30-B16F-BC15294242BDQ21107313-33925B2A-52A4-40F6-B9C6-9893E9E27692Q21107468-194ADD33-AFF0-4F94-AE15-FA72D2384FC2Q21107646-B2E47AB7-0ABB-4594-AB51-D09C3D444A13Q21108767-53C671AF-85F2-456A-AD28-DC6B0C06EDE8Q21108995-7EE4BA8C-106F-493D-B72B-E65A4DBC32BDQ21109091-15275703-BA68-4948-9532-B1ABCD9927D5Q21109679-5F2D8A76-7870-47E6-A95F-B705FB74553DQ21110024-477D3E00-CA6D-45FD-9AB7-015E629B6E36Q21111579-5B88E1CC-9795-434A-A5F9-EEDCB272A61AQ21111916-5F52F836-1938-4A22-A825-1C507B43C4DDQ21113391-FB8AE022-DBD6-4230-B3BD-6A559D486620Q21114338-C2DF1620-DAF2-4726-8C7F-3603787D4B33Q21114530-4FA645BA-955B-4ACE-B3ED-234B63CFCBABQ21114866-52521940-3126-4A2D-8C75-D403142DEB23Q21114975-6705A1CB-7D80-435A-8E63-5CE5318E095EQ21115551-A09EFAB1-6B00-46FF-867E-4F4DB69EAC4EQ21115777-28044614-0EA1-4D77-90AE-84DD9C95023F
P682
Q22010236-9F5429C3-6FCD-4FBE-B5D7-43958381F64BQ22253856-AF3B27C5-54D7-4B6D-A85D-AB67CD095294Q22254093-84EAB691-6A00-44D4-8DB8-BC83A0A00A83Q24297626-958907E6-5964-49FE-80EE-8A8D3C9CADF5Q24297786-B8219131-BE02-4082-9854-540074D15284Q24299593-6EED5832-075A-4040-92EB-E5C446D1ECA1Q24301515-2FED3451-B372-4B42-8BF1-F770535DEE5EQ24308787-AF3B82F3-582E-40E3-9E5F-DAC239EAFA12Q24310185-2634EDFC-B31C-46D5-8F25-7F91B418FE98Q24310466-677EB139-300B-4E4C-A9B7-8EE7B5CB14D9Q24310957-D7B4F049-BA64-4557-BA58-A739CBD26136Q24317709-97697700-23BB-476E-BDA7-546773543692Q24317773-3AFDDBE7-6119-4D9C-97E5-1AEEE37E24A0Q24322941-164B94DE-6840-4196-81A8-AAD4B25AC63CQ28771714-DD3423B5-FFF1-4415-80BD-2E2A9549AF8C
P921
description
Any process that results in a ...... cating damage to the organism.
@en
biologisch proces
@nl
name
respons på skade
@nn
response to wounding
@en
type
label
respons på skade
@nn
response to wounding
@en
altLabel
GO:0009611
@en
fysiologisk respons på skade
@nn
physiological response to wounding
@en
reaksjon på skade
@nn
skaderespons
@nn
prefLabel
respons på skade
@nn
response to wounding
@en
P2888
P686
GO:0009611